Pediatric Adenotonsillectomy Trial for Snoring

NCT02562040 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 459

Last updated 2024-11-15

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the effects of early adenotonsillectomy (eAT) on the behavior, sleep-disordered breathing symptoms and quality of life for children who snore, but do not have obstructive sleep apnea, as well as identify factors that moderate responses to the surgery. Half of participants will receive eAT, while the other half will be observed with watchful waiting and supportive care.

Conditions

  • Sleep-Disordered Breathing

Interventions

PROCEDURE

Early Adenotonsillectomy (eAT)

Standard clinical adenotonsillectomy within 4 weeks post randomization in addition to information about healthy sleep habits for children and appropriate clinical referrals for management of co-morbidities.

BEHAVIORAL

Watchful Waiting with Supportive Care (WWSC)

Information about healthy sleep habits for children and appropriate clinical referrals for management of co-morbidities.

Sponsors & Collaborators

  • Children's Hospital of Philadelphia

    collaborator OTHER
  • University Hospitals Cleveland Medical Center

    collaborator OTHER
  • Children's Hospital Medical Center, Cincinnati

    collaborator OTHER
  • University of Michigan

    collaborator OTHER
  • University of Texas Southwestern Medical Center

    collaborator OTHER
  • University of Rochester

    collaborator OTHER
  • Children's Hospital of The King's Daughters

    collaborator OTHER
  • Boston Children's Hospital

    collaborator OTHER
  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Susan S Redline, MD, MPH · Brigham and Women's Hospital

  • Rui Wang, PhD · Brigham and Women's Hospital

  • Susan L. Furth, MD, PhD · Children's Hospital of Philadelphia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-06
Primary Completion
2022-02-21
Completion
2022-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02562040 on ClinicalTrials.gov